Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04510779 · ClinicalTrials.gov registry record · NA
Apple Watch Heart Failure Study
A NA study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04510779 is a NA study that has completed, run by Tufts Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT04510779, a NA study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a pilot/feasibility study on the accuracy of HRV as measured by the Apple Watch on heart failure patients who are admitted to the hospital with heart failure exacerbation. The primary aim is to observe a statistically significant improvement in the HRV of acutely decompensated heart failure patients upon discharge when compared to admission, implying the utility of HRV measured by Apple Watch as a monitor for cardiovascular health.
Interventions
- DEVICE Apple Watch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-05-09 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04510779
The ClinicalTrials.gov registry entry for NCT04510779 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Apple Watch is the first listed.
NCT04510779 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04510779 about?
NCT04510779 is a clinical study titled "Apple Watch Heart Failure Study". This is a pilot/feasibility study on the accuracy of HRV as measured by the Apple Watch on heart failure patients who are admitted to the hospital with heart failure exacerbation. The primary aim is to observe a statistically significant improvement in the HRV of acutely decompensated heart failure ...
What is the current status of trial NCT04510779?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-05-09. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04510779?
The interventions under investigation include: Apple Watch (DEVICE).
Who is sponsoring clinical trial NCT04510779?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.